The results of Gallerano et al. [26] identified for the first time a single nucleotide polymorphism (SNP rs10748643 A > G) as a genetic factor for CD39 expression in CD8+ T cells in CRC patients and demonstrated the inhibitory effect of CD39+CD8+ T cells in vitro. This evidence concerns the gene CD8A and colorectal carcinoma.